Model Number 810081 |
Device Problem
Migration (4003)
|
Patient Problems
Erosion (1750); Pain (1994); Not Applicable (3189)
|
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2018 through november 30, 2018.(b)(4).Total number of events ¿ 644.Tension free vaginal tape - 210; tension free vaginal tape ¿ abbrevo - 15; tension free vaginal tape ¿ abdominal - 12; tension free vaginal tape ¿ exact - 40; tension free vaginal tape ¿ obturator - 265; tension free vaginal tape ¿ retropubic - 102.
|
|
Event Description
|
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2007 and the mesh was implanted.It was reported that she experienced dyspareunia and erosion.It was also reported that the patient has undergone revisionary procedures.No further information is available.
|
|
Manufacturer Narrative
|
Date sent to fda: 4/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to fda: 2/11/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to fda: 6/25/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to fda: 8/23/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to fda: 10/25/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/21/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to fda: 10/22/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Manufacturer Narrative
|
Date sent to the fda: 8/24/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period august 1, 2018 through september 31, 2018.
|
|
Manufacturer Narrative
|
Date sent to the fda: 08/25/2020.Corrected narrative for follow up number 7: ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2018 through november 30, 2018.
|
|
Search Alerts/Recalls
|